PensionDanmark Pensionsforsikringsaktieselskab Purchases 1,900 Shares of Humana Inc. $HUM

PensionDanmark Pensionsforsikringsaktieselskab grew its position in Humana Inc. (NYSE:HUM) by 10.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,163 shares of the insurance provider’s stock after purchasing an additional 1,900 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Humana were worth $8,009,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Vanguard Group Inc. lifted its position in shares of Humana by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock worth $3,652,890,000 after buying an additional 106,030 shares in the last quarter. Capital International Investors increased its position in shares of Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after acquiring an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC lifted its holdings in Humana by 34.3% during the first quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the period. State Street Corp boosted its position in Humana by 1.8% in the fourth quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock worth $1,403,877,000 after purchasing an additional 97,211 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in Humana by 28.9% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock worth $1,151,759,000 after purchasing an additional 1,008,514 shares during the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Performance

Shares of HUM opened at $384.44 on Friday. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $428.88. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. The stock’s fifty day moving average price is $377.18 and its two-hundred day moving average price is $271.65. The firm has a market cap of $46.16 billion, a PE ratio of 36.37, a PEG ratio of 2.20 and a beta of 0.72.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the prior year, the company earned $6.27 EPS. The firm’s quarterly revenue was up 26.2% compared to the same quarter last year. On average, equities research analysts forecast that Humana Inc. will post 9.08 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on HUM shares. Truist Financial raised their target price on Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Oppenheimer restated an “outperform” rating and set a $405.00 price target on shares of Humana in a research report on Thursday, July 30th. Deutsche Bank Aktiengesellschaft assumed coverage on shares of Humana in a report on Thursday, July 30th. They set a “hold” rating for the company. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $214.00 to $316.00 and gave the stock a “neutral” rating in a research report on Monday, June 8th. Finally, Piper Sandler upgraded shares of Humana from a “hold” rating to an “overweight” rating and set a $463.00 target price on the stock in a research note on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, fourteen have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $391.87.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.